Strategic acquisitions mPulse has pursued multiple acquisitions since 2021, including Zipari in 2024 and Clarity Software Solutions in 2025, signaling a growth strategy that could open cross-sell opportunities forHXI offerings, analytics, and patient navigation solutions to newly added client bases.

Scale and reach With 501-1000 employees and revenues in the high hundreds of millions, mPulse operates at enterprise scale, suggesting readiness to engage with large health systems and multi-site networks for comprehensive Health Experience and Insights deployments.

Funding and guidance A history of substantial funding including a 2020 Series C of over $16M backed by Optum Ventures and other prominent investors indicates strong financial health and strategic backing, reducing procurement risk for enterprise partnerships and long-term contracts.

Expanding product suite Recent product developments such as Measures within Decision Point Insights and targeted engagement solutions for pregnancy reflect a broadening HX I capability set, presenting upsell and cross-sell opportunities across payer, provider, and consumer health segments.

Industry footprint As a trusted partner to over 450 healthcare organizations and with extensive consumer transaction volumes, mPulse offers a proven track record for health experience optimization, creating compelling reference opportunities and credentialing leverage for new client acquisitions.